Mitch Davis (pictured), an employee benefits advisor at Gallagher, did not enter the industry by design. He arrived by invitation, one extended by a mentor who understood what the industry needed was less someone who could read a spreadsheet and more someone who could read a room.
Davis grew up in Carmel, Indiana, in a household that served as a host family for foster children. Between the age of five and his departure for Indiana University in Bloomington, around 50 to 60 children passed through the Davis family home. In a suburb known for its prosperity, the experience gave Davis something rare: a close-quarters view of vulnerability, hardship and resilience that comfortable neighborhoods rarely cultivate.
"The foster child experience showed me how to understand people from different realms and the challenges that people are feeling," he says. "That parlayed into my interest in nonprofits and working with mission-driven organizations."
But when the then-president of Assured Partners reached out during his college years, Davis was not a willing convert. "Insurance isn't the sexiest business," he recalls being told, "but I think you would do well at it and I'd really love you to give it a shot." He trusted the man he describes as the best leader he has ever met, a great storyteller who knows how to captivate an audience. An internship followed, then a full-time role in 2018. He has not looked back since.
He went straight into employee benefits, and the reasoning he gives reveals a mind that was already thinking in systems. From an employer's perspective, property and casualty tends to be reduced to a single objective: the lowest possible premium. Benefits, by contrast, is altogether more layered. "There are so many tentacles that spread from what that does for a business," Davis says. "Employee benefits is really the heart of how you attract and retain talent." The people element sealed it for him, and it shows.
For decades, the group benefits industry operated on what Davis calls the old quoting playbook: brokers sent to market, returning with three options on a spreadsheet, a client picking one without real context, narrative or understanding. Davis, a Greater Indianapolis-based advisor who joined Gallagher in 2019, is direct about the damage this has caused. "That is what has really driven the confusion and the lack of trust."
To break that cycle, Davis begins differently. Rather than leading with data requests, he gathers CFOs, HR leaders and operational decision makers around a single conversation about their business strategy rather than insurance options. Gallagher facilitates; the client does the heavy lifting.
The reason this is not widely adopted, Davis suggests, is that it requires advisors to delay the transaction, and most compensation structures do not reward that kind of patience.
One success story Davis highlights involved him building a direct line between the client's leadership and the underwriting team, coaching both. Through that dialogue, a critical piece of context emerged: the company was navigating private equity interest and needed to demonstrate specific financial performance to prospective partners. Once the underwriter understood what was at stake, the conversation changed entirely. The result was a long-term contract rather than another 12-month renewal cycle, and a cost reduction of $300,000.
Ask Davis what is keeping CFOs awake in 2026 and the answer comes quickly: pharmacy. Specialty medications and an expanding universe of gene therapies are driving a growing share of employer plan spend, and GLP-1 drugs, he says, are not going away as a topic anytime soon. Cancer claims on stop-loss data are also rising sharply.
Two strategies are driving Gallagher's response on the pharmacy front. The first is international sourcing for medications, a concept that unsettles some clients at first presentation, but one Davis argues can reduce the cost of high-cost specialty drugs by 30 to 70 percent. The incentive for employees is the elimination of copays when they participate, because simply telling a workforce that a new program will save the company money, without explaining what is in it for them, is a reliable way to generate resentment rather than engagement.
The second strategy targets the pharmacy benefit manager (PBM) and the opacity Davis describes with barely concealed frustration. When pharmacy coverage is bundled with a medical plan, the carrier has no structural incentive to negotiate drug prices down because every dollar flows back through them. For self-funded employers, the solution is to carve out the PBM contract entirely, selecting transparent partners and insisting on quarterly audits.
The audits matter because the contractual language often does not mean what it appears to mean. Terms can be written, Davis explains, to allow a PBM to move results between categories and create the impression that guarantees have been met when they have not. "Those quarterly audits really uncover whether they are staying true to the contract terms that we established," he says.
Moving targets are evident in healthcare pricing, too. A knee replacement at one hospital might cost $18,000. At another facility in the same city, $80,000. "How do we not have a consistent pricing system so that people know what things cost when they walk through the door?" Davis asks. "The funny part about it is a lot of times the higher quality providers actually cost less than the lower quality."
The behavioral trap is well established. Employees who have already met their deductible and out-of-pocket maximum through a year of treatment are not thinking about cost when they schedule surgery. They are thinking about convenience: which hospital can take them fastest and which is closest to home. "They don't even know the cost because, hey, they're not paying it," Davis says. What they do not see is the downstream effect on their employer's renewal rates.
Davis's answer is the center of excellence model. Gallagher has established direct contracts with leading providers across the country, including Rush hospital in Chicago, whose orthopedic surgeons operate on the city's professional sports franchises. Under these arrangements, procedures that might cost $80,000 on the open network are agreed at fixed rates, say $22,000. The employee pays nothing out of pocket, travel costs are covered, and the employer recoups the difference. "You're saving $60,000 in claims costs by just allowing the employee to get it done for free at a really high-quality hospital," Davis observes.
Among the programs Davis discusses with enthusiasm is on-site cancer screening, a preventive intervention that is, he argues, one of the most powerful culture-building tools available to an employer right now.
Standard primary care visits screen for approximately five types of cancer. Davis's partners arrive in a branded truck, set up in an employer's parking lot, and offer employees a two-minute saliva and blood test covering around 85 different cancers. "Employees absolutely love it," Davis says, because cancer is present in almost every family and early detection changes outcomes materially. Spouses can participate alongside employees, and a positive result triggers immediate guidance toward the right clinical pathway.
The financial case is clean. "You catch one cancer that more than pays for itself as an employer, when you think about what the claim could be." The cultural case may be equally compelling: an employer that invests visibly in its people's health sends a signal that no benefits booklet can replicate. As Davis learned early, life comes down to people.
